Dr. Beat M. Frey

Further involvements

• 22/09/2022

  09:20 – 09:30 6 Min. 4 Min.

  • Abstractvortrag
  • VS-9-4

  Flowcytometry-based phagocytosis assay of DAT+ erythrocytes as in-vitro surrogate for immune-mediated hemolysis

   18. Zukunftsgebiete der Transfusionsmedizin, 7. Immunhämatologie und Immunologische Grundlagen
• 22/09/2022

  17:10 – 17:15 3 Min. 2 Min.

  • Poster
  • PS-3-9

  Case report: Severe drug-induced immune hemolytic anemia due to ceftriaxone

   20. Pädiatrische Transfusionsmedizin, 7. Immunhämatologie und Immunologische Grundlagen
• 22/09/2022

  17:55 – 18:00 3 Min. 2 Min.

  • Poster
  • PS-3-18

  Diagnostics and blood management of an infant with McLeod contiguous gene deletion syndrome

   20. Pädiatrische Transfusionsmedizin, 9. Hämotherapie
• 23/09/2022

  09:00 – 09:10 6 Min. 4 Min.

  • Abstractvortrag
  • VS-21-4

  RHD Donor screening in Switzerland: Resolving novel alleles by nanopore-sequencing

   18. Zukunftsgebiete der Transfusionsmedizin, 7. Immunhämatologie und Immunologische Grundlagen
• 23/09/2022

  09:10 – 09:20 6 Min. 4 Min.

  • Abstractvortrag
  • VS-21-5

  Case example of Nanopore sequencing for resolving genotype-phenotype discrepancies in the Duffy blood group at haplotype scale: discovery of a novel null allele in a FY*A/FY*B heterozygous individual

   7. Immunhämatologie und Immunologische Grundlagen, 8. Immungenetik: HLA und Transplantationen
• 23/09/2022

  09:30 – 09:40 6 Min. 4 Min.

  • Abstractvortrag
  • VS-21-7

  Third-generation sequencing detects a novel variant in the regulatory RUNX1 motif of the ABO gene causing mixed-field agglutination in an AB individual

   7. Immunhämatologie und Immunologische Grundlagen, 8. Immungenetik: HLA und Transplantationen